Open access
60
Views
8
CrossRef citations to date
0
Altmetric
Original Research
Double-blind comparison of ziprasidone and risperidone in the treatment of Chinese patients with acute exacerbation of schizophrenia
Hongyan Zhang1 Institute of Mental Health, Peking University, Beijing, ChinaCorrespondence[email protected]
, Huafang Li2 Shanghai Mental Health Center, Shanghai, China
, Liang Shu1 Institute of Mental Health, Peking University, Beijing, China
, Niufan Gu2 Shanghai Mental Health Center, Shanghai, China
, Gang Wang3 Capital Medical University, Beijing An Ding Hospital, Beijing, China
, Yongzhen Weng3 Capital Medical University, Beijing An Ding Hospital, Beijing, China
, Shiping Xie4 Nanjing Brain Hospital, Nanjing, China
, Xinbao Zhang4 Nanjing Brain Hospital, Nanjing, China
, Ting Li5 Guangzhou Brain Hospital, Guangzhou, China
, Cui Ma5 Guangzhou Brain Hospital, Guangzhou, China
, Wei Yu6 Pfizer China, Beijing, China
, Bruce Parsons7 Pfizer Inc, New York, NY, USA
& Manjula Schou8 Pfizer Australia, Sydney, Australia
show all
Pages 77-85
|
Published online: 04 Mar 2011
Reprints and Permissions
Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.
To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.
For more information please visit our Permissions help page.
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.